Sphingosine 1-phosphate

Sphingosine 1-phosphate is a lipid of Sphingolipids (SP) class. Sphingosine 1-phosphate is associated with abnormalities such as Infection, Painful Bladder Syndrome, Atherosclerosis, Hyperglycemia and Rheumatoid Arthritis. The involved functions are known as Phosphorylation, Regulation, enzyme activity, Energy Absorption and Vascular Permeability. Sphingosine 1-phosphate often locates in Endothelium, Tissue membrane, Vascular System, Protoplasm and Microfilaments. The associated genes with Sphingosine 1-phosphate are MBTPS1 gene, FBXL15 gene, TEK gene, NTRK1 gene and Gene Family. The related lipids are Promega, Lipopolysaccharides, lysophosphatidic acid, Lysophosphatidylcholines and Lysophospholipids. The related experimental models are Knock-out, Mouse Model, Transgenic Model, Disease model and Experimental Autoimmune Encephalomyelitis.

Cross Reference

Introduction

To understand associated biological information of Sphingosine 1-phosphate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Sphingosine 1-phosphate?

Sphingosine 1-phosphate is suspected in Lymphopenia, Ischemia, Infection, Atherosclerosis, Multiple Sclerosis, Asthma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Sphingosine 1-phosphate

PubChem Associated disorders and diseases

What pathways are associated with Sphingosine 1-phosphate

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Sphingosine 1-phosphate through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Sphingosine 1-phosphate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Sphingosine 1-phosphate?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Sphingosine 1-phosphate?

Knock-out

Knock-out are used in the study 'Sphingosine 1-phosphate-dependent trafficking of peritoneal B cells requires functional NFkappaB-inducing kinase in stromal cells.' (Kunisawa J et al., 2008), Knock-out are used in the study 'Connective tissue growth factor (CTGF/CCN2) mediates angiogenic effect of S1P in human dermal microvascular endothelial cells.' (Markiewicz M et al., 2011), Knock-out are used in the study 'Chasing sphingosine-1-phosphate, a lipid mediator for cardiomyocyte survival.' (Yang Q, 2007), Knock-out are used in the study 'Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function.' (Idzko M et al., 2006) and Knock-out are used in the study 'Platelet endothelial cell adhesion molecule-1 modulates endothelial cell motility through the small G-protein Rho.' (Gratzinger D et al., 2003).

Mouse Model

Mouse Model are used in the study 'Regulation of the micromechanical properties of pulmonary endothelium by S1P and thrombin: role of cortactin.' (Arce FT et al., 2008), Mouse Model are used in the study 'Sequential delivery of vascular endothelial growth factor and sphingosine 1-phosphate for angiogenesis.' (Tengood JE et al., 2010), Mouse Model are used in the study 'S1P(5) is required for sphingosine 1-phosphate-induced autophagy in human prostate cancer PC-3 cells.' (Chang CL et al., 2009), Mouse Model are used in the study 'Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages.' (Hughes JE et al., 2008) and Mouse Model are used in the study 'The alliance of sphingosine-1-phosphate and its receptors in immunity.' (Rivera J et al., 2008).

Transgenic Model

Transgenic Model are used in the study 'Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.' (Augé N et al., 2004), Transgenic Model are used in the study 'Sphingosine-1-phosphate antibodies as potential agents in the treatment of cancer and age-related macular degeneration.' (Sabbadini RA, 2011) and Transgenic Model are used in the study 'Still benched on its way to the bedside: sphingosine kinase 1 as an emerging target in cancer chemotherapy.' (Gault CR and Obeid LM, 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Sphingosine 1-phosphate

Download all related citations
Per page 10 20 50 100 | Total 2896
Authors Title Published Journal PubMed Link
Desai P et al. Dyslipidemia regulates thrombospondin-1-induced vascular smooth muscle cell chemotaxis. 2015 Mol. Cell. Biochem. pmid:26350564
Nojima H et al. Sphingolipids in liver injury, repair and regeneration. 2015 Biol. Chem. pmid:25781682
Newton J et al. Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy. 2015 Exp. Cell Res. pmid:25770011
O'Sullivan C and Dev KK Galactosylsphingosine (psychosine)-induced demyelination is attenuated by sphingosine 1-phosphate signalling. 2015 J. Cell. Sci. pmid:26359302
Nofer JR Signal transduction by HDL: agonists, receptors, and signaling cascades. 2015 Handb Exp Pharmacol pmid:25522990
Baranowski M et al. Exercise increases sphingoid base-1-phosphate levels in human blood and skeletal muscle in a time- and intensity-dependent manner. 2015 Eur. J. Appl. Physiol. pmid:25519954
Klocke S et al. Slow-freezing versus vitrification for human ovarian tissue cryopreservation. 2015 Arch. Gynecol. Obstet. pmid:25115279
Burow P et al. Activation of ATP secretion via volume-regulated anion channels by sphingosine-1-phosphate in RAW macrophages. 2015 Pflugers Arch. pmid:24965069
Jones EE et al. Tissue biomarkers of drug efficacy: case studies using a MALDI-MSI workflow. 2015 Bioanalysis pmid:26505686
Kim ES et al. A natural piper-amide-like compound NED-135 exhibits a potent inhibitory effect on the invasive breast cancer cells. 2015 Chem. Biol. Interact. pmid:25980589
Schaffert SA et al. mir-181a-1/b-1 Modulates Tolerance through Opposing Activities in Selection and Peripheral T Cell Function. 2015 J. Immunol. pmid:26163591
Gao Y et al. Sphingosine kinase 1 as an anticancer therapeutic target. 2015 Drug Des Devel Ther pmid:26150697
Tian H and Yu Z Resveratrol induces apoptosis of leukemia cell line K562 by modulation of sphingosine kinase-1 pathway. 2015 Int J Clin Exp Pathol pmid:26045781
Trayssac M et al. Role of Sphingosine-1-Phosphate in Transplant Vasculopathy Evoked by Anti-HLA Antibody. 2015 Am. J. Transplant. pmid:25930666
Pulkoski-Gross MJ et al. Sphingosine-1-phosphate metabolism: A structural perspective. 2015 Crit. Rev. Biochem. Mol. Biol. pmid:25923252
Ader I et al. Neutralizing S1P inhibits intratumoral hypoxia, induces vascular remodelling and sensitizes to chemotherapy in prostate cancer. 2015 Oncotarget pmid:25915662
Rao PV Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma. 2014 Mar-Apr J Ocul Pharmacol Ther pmid:24283588
Völzke A et al. Sphingosine 1-phosphate (S1P) induces COX-2 expression and PGE2 formation via S1P receptor 2 in renal mesangial cells. 2014 Biochim. Biophys. Acta pmid:24064301
Pyne NJ et al. The role of sphingosine 1-phosphate in inflammation and cancer. 2014 Adv Biol Regul pmid:24070975
Nguyen-Tran DH et al. Molecular mechanism of sphingosine-1-phosphate action in Duchenne muscular dystrophy. 2014 Dis Model Mech pmid:24077965
Anderson G and Maes M Reconceptualizing adult neurogenesis: role for sphingosine-1-phosphate and fibroblast growth factor-1 in co-ordinating astrocyte-neuronal precursor interactions. 2014 CNS Neurol Disord Drug Targets pmid:24040808
Kim YI et al. An endoplasmic reticulum stress-initiated sphingolipid metabolite, ceramide-1-phosphate, regulates epithelial innate immunity by stimulating β-defensin production. 2014 Mol. Cell. Biol. pmid:25312644
Ito K et al. Integrin α9 on lymphatic endothelial cells regulates lymphocyte egress. 2014 Proc. Natl. Acad. Sci. U.S.A. pmid:24516133
Takeshita E et al. Diacylglycerol kinase γ is a novel anionic phospholipid binding protein with a selective binding preference. 2014 Biochem. Biophys. Res. Commun. pmid:24486543
Kamiya T et al. Role of Ca2+ -dependent and Ca2+ -sensitive mechanisms in sphingosine 1-phosphate-induced constriction of isolated porcine retinal arterioles in vitro. 2014 Exp. Eye Res. pmid:24486793
Plano D et al. Importance of sphingosine kinase (SphK) as a target in developing cancer therapeutics and recent developments in the synthesis of novel SphK inhibitors. 2014 J. Med. Chem. pmid:24471412
Bradley E et al. Critical role of Spns2, a sphingosine-1-phosphate transporter, in lung cancer cell survival and migration. 2014 PLoS ONE pmid:25330231
Xu H et al. Sphingosine-1-phosphate receptor agonist, FTY720, restores coronary flow reserve in diabetic rats. 2014 Circ. J. pmid:25319164
Fukui H et al. S1P-Yap1 signaling regulates endoderm formation required for cardiac precursor cell migration in zebrafish. 2014 Dev. Cell pmid:25313964
Obinata H et al. Individual variation of human S1P₁ coding sequence leads to heterogeneity in receptor function and drug interactions. 2014 J. Lipid Res. pmid:25293589
St John AL et al. S1P-Dependent trafficking of intracellular yersinia pestis through lymph nodes establishes Buboes and systemic infection. 2014 Immunity pmid:25238098
Davis KM and Isberg RR Plague's partners in crime. 2014 Immunity pmid:25238090
Bi Y et al. Sphingosine-1-phosphate mediates a reciprocal signaling pathway between stellate cells and cancer cells that promotes pancreatic cancer growth. 2014 Am. J. Pathol. pmid:25111230
Ishitsuka A et al. FTY720 and cisplatin synergistically induce the death of cisplatin-resistant melanoma cells through the downregulation of the PI3K pathway and the decrease in epidermal growth factor receptor expression. 2014 Int. J. Mol. Med. pmid:25109763
Xiong H et al. SphK1 confers resistance to apoptosis in gastric cancer cells by downregulating Bim via stimulating Akt/FoxO3a signaling. 2014 Oncol. Rep. pmid:25109605
Zhao X et al. Induction of the matricellular protein CCN1 through RhoA and MRTF-A contributes to ischemic cardioprotection. 2014 J. Mol. Cell. Cardiol. pmid:25106095
Li MH et al. Induction of chemokine (C-C motif) ligand 2 by sphingosine-1-phosphate signaling in neuroblastoma. 2014 J. Pediatr. Surg. pmid:25092091
Tarbell JM et al. Mechanosensing at the vascular interface. 2014 Annu Rev Biomed Eng pmid:24905872
Potì F et al. Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P). 2014 Cardiovasc. Res. pmid:24891400
Chawla S et al. Exogenous sphingosine-1-phosphate boosts acclimatization in rats exposed to acute hypobaric hypoxia: assessment of haematological and metabolic effects. 2014 PLoS ONE pmid:24887065
Janes K et al. The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1. 2014 J. Biol. Chem. pmid:24876379
Smyth SS et al. Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis. 2014 Arterioscler. Thromb. Vasc. Biol. pmid:24482375
Takabe K and Spiegel S Export of sphingosine-1-phosphate and cancer progression. 2014 J. Lipid Res. pmid:24474820
Ishizawa S et al. Sphingosine-1-phosphate induces differentiation of cultured renal tubular epithelial cells under Rho kinase activation via the S1P2 receptor. 2014 Clin. Exp. Nephrol. pmid:24463961
Couttas TA et al. Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer's disease pathogenesis. 2014 Acta Neuropathol Commun pmid:24456642
Gassowska M et al. Sphingosine kinases/sphingosine-1-phosphate and death Signalling in APP-transfected cells. 2014 Neurochem. Res. pmid:24452756
Abu El-Asrar AM et al. Expression of bioactive lysophospholipids and processing enzymes in the vitreous from patients with proliferative diabetic retinopathy. 2014 Lipids Health Dis pmid:25496321
Jensen T et al. The identification of GPR3 inverse agonist AF64394; the first small molecule inhibitor of GPR3 receptor function. 2014 Bioorg. Med. Chem. Lett. pmid:25442311
Ye C et al. Identification of a novel small-molecule agonist for human G protein-coupled receptor 3. 2014 J. Pharmacol. Exp. Ther. pmid:24633425
Pyszko J and Strosznajder JB Sphingosine kinase 1 and sphingosine-1-phosphate in oxidative stress evoked by 1-methyl-4-phenylpyridinium (MPP+) in human dopaminergic neuronal cells. 2014 Mol. Neurobiol. pmid:24399507